Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics and Genomics

Background:

• Myelin defects lead to various brain disorders, but a lack of human models hinders understanding of their pathological mechanisms.
• Existing human induced pluripotent stem cell (hiPSC)-derived brain models struggle to replicate mature myelination, limiting their utility for studying myelin diseases.

Purpose of the Study:

• To develop a robust and reproducible method for generating 3D myelin spheroids from hiPSCs.
• To establish a human cellular platform for modeling myelin diseases, specifically Canavan disease (CD), and facilitating mechanistic studies and drug discovery.

Main Methods:

• Generation of three-dimensional (3D) myelin spheroids from hiPSCs.
• Utilizing patient-derived iPSCs to create a disease-specific model for Canavan disease.
• Treatment of CD patient iPSC-derived myelin spheroids with N-acetyl-aspartate (NAA) to investigate disease pathology.

Main Results:

• Successfully generated 3D myelin spheroids from hiPSCs in a reproducible manner.
• The developed model recapitulated key pathological features of Canavan disease.
• Demonstrated that elevated levels of N-acetyl-aspartate (NAA) are sufficient to induce myelin sheath toxicity in the model.

Conclusions:

• Established a novel 3D human cellular platform for modeling human myelin diseases.
• The myelin spheroid model provides a valuable tool for understanding myelin disease mechanisms and for drug discovery.
• Confirmed the direct toxicity of high N-acetyl-aspartate levels on myelin, a key finding for Canavan disease research.